Irisin, a novel myokine is an independent predictor for sarcopenia and carotid atherosclerosis in dialysis patients
Mi Jung Lee(Yonsei University Health System), Tae‐Hyun Yoo(Yonsei University), Shin‐Wook Kang(Yonsei University), Hyung Jung Oh(Yonsei University), Dong‐Ryeol Ryu(Ewha Womans University), Seung Hyeok Han(Yonsei University), Yung Ly Kim(Yonsei University), Sul A Lee(Massachusetts General Hospital), Sungha Park(Severance Hospital), Jung Tak Park(FIND), Sang‐Hak Lee(Armed Forces Capital Hospital), Kyoung Sook Park(Yonsei University), Young Eun Kwon(Yonsei University), Bo Young Nam(Yonsei University), Han Jak Ryu(Yonsei University)
Cited by 96
Related Papers
Characterization of ferroptosis in kidney tubular cell death under diabetic conditions
|Cell Death and Disease|2021|298
2018 Guidelines for the management of dyslipidemia
|The Korean Journal of Internal Medicine|2019|214
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics
|Nephrology Dialysis Transplantation|2020|189
2018 Guidelines for the Management of Dyslipidemia in Korea
|Journal of Lipid and Atherosclerosis|2019|187
Circulating α-Klotho Levels in CKD and Relationship to Progression
|American Journal of Kidney Diseases|2013|184